Rockefeller Capital Management
MIST icon

Rockefeller Capital Management’s Milestone Pharmaceuticals MIST Stock Holding History

Rockefeller Capital Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8K Hold
12,500
– – ﹤0.01% 3802
2026
Q1 		$14.9K Buy
12,500
+10,800
+635% +$18.9K ﹤0.01% 3833
2025
Q4 		$3.43K Buy
+1,700
New +$3.66K ﹤0.01% 4181

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Rockefeller Capital Management's MIST Position: Q2 2026 in Review

Rockefeller Capital Management held its Milestone Pharmaceuticals (MIST) position steady in Q2 2026 at 12,500 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3802.

Rockefeller Capital Management first reported a position in MIST in Q4 2025 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Rockefeller Capital Management held 12,500 shares of Milestone Pharmaceuticals worth $16.8K as of Q2 2026.
  • Rockefeller Capital Management left its Milestone Pharmaceuticals share count unchanged in Q2 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3802 holding.
  • Rockefeller Capital Management first reported a position in Milestone Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.